Revenue and market share shortfalls due to the timing of adoption by medical institutions and response to demand
First written in FY2024. 1 of 2 entries say "Materialised", first in FY2025-H1. Latest entry: FY2025-H1.
No other company in this theme has enough history to compare yet.
- FY2025-H1MaterialisedAnnual report
「Although needs and inquiries from existing users, particularly concerning DX-related systems, continue, some medical institutions have been postponing implementation because of deteriorating operating conditions.」
The company stated that some medical institutions have in fact postponed the implementation of medical information systems because of deteriorating operating conditions. - FY2024First statedAnnual report
「Although there is demand for the digitization of healthcare, the timing of implementation also depends on medical institutions’ budgets, capital investment priorities and strategies. As a result, if we fail to achieve the expected revenue and market share, this could affect the group’s performance. Over the medium to long term, the group’s performance could also be affected if we fail to capture opportunities because we cannot respond to demand for medical information systems within a short period, if the replacement market becomes more active and stock-based revenue is lost or reduced, or if intensified competition among several major vendors leads to substantial cuts in selling prices and prevents us from achieving the expected revenue and market share.」
The company newly presented, as a group of risks to revenue and market-share targets, changes in implementation timing due to medical institutions’ budgets and capital investment priorities, lost opportunities caused by delays in responding to demand, a reduction in stock-based revenue due to replacements, and selling-price reductions resulting from intensified competition.